| Item Type | Name |
|
Academic Article
|
Preventing recurrent depression: long-term treatment for major depressive disorder.
|
|
Academic Article
|
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
|
|
Academic Article
|
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
|
|
Academic Article
|
Treating depression to remission.
|
|
Academic Article
|
SNRIs in the management of acute major depressive disorder.
|
|
Academic Article
|
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
|
|
Academic Article
|
The Modified Rush Sexual Inventory: preliminary psychometric findings.
|
|
Academic Article
|
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
|
|
Academic Article
|
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
|
|
Academic Article
|
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
|
|
Academic Article
|
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
|
|
Academic Article
|
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
|
|
Academic Article
|
Augmentation strategies to increase antidepressant tolerability.
|
|
Academic Article
|
Oral divalproex sodium loading for adolescent outpatients with acute mania/hypomania: a report of 2 cases.
|
|
Academic Article
|
Evidence for the use of l-methylfolate combined with antidepressants in MDD.
|
|
Academic Article
|
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.
|
|
Academic Article
|
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.
|
|
Academic Article
|
Residual symptoms in major depressive disorder: prevalence, effects, and management.
|
|
Academic Article
|
Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances.
|
|
Academic Article
|
Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial.
|
|
Academic Article
|
A systematized approach to the management of the depressed and anxious patient.
|
|
Academic Article
|
Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.
|
|
Academic Article
|
Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs.
|
|
Academic Article
|
Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study.
|
|
Academic Article
|
Notice of Retraction and Replacement. Hollon et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(10):1157-1164.
|
|
Academic Article
|
Does folic acid interfere with lamotrigine?
|
|
Academic Article
|
Susceptibility to spontaneous MAOI hypertensive episodes.
|
|
Academic Article
|
The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction.
|
|
Academic Article
|
The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
|
|
Academic Article
|
Management of comorbid anxiety and depression.
|
|
Academic Article
|
Divalproex sodium in the treatment of refractory affective disorders.
|
|
Academic Article
|
The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
|
|
Academic Article
|
Importance of establishing the diagnosis of persistent anxiety.
|
|
Academic Article
|
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
|
|
Academic Article
|
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.
|
|
Academic Article
|
Clinical management of antidepressant discontinuation.
|
|
Academic Article
|
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
|
|
Academic Article
|
Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.
|
|
Academic Article
|
Changes in adverse events reported by patients during 6 months of fluoxetine therapy.
|
|
Academic Article
|
Changes in weight during a 1-year trial of fluoxetine.
|
|
Academic Article
|
Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
|
|
Academic Article
|
Clinical issues in long-term treatment with antidepressants.
|
|
Academic Article
|
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.
|
|
Academic Article
|
Strategies for the treatment of antidepressant-related sexual dysfunction.
|
|
Academic Article
|
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
|
|
Academic Article
|
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
|
|
Academic Article
|
Six-year perspectives on the safety and tolerability of nefazodone.
|
|
Academic Article
|
Antidepressant dosing and switching guidelines: focus on nefazodone.
|
|
Academic Article
|
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
|
|
Academic Article
|
A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.
|
|
Academic Article
|
Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.
|
|
Academic Article
|
A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
|
|
Academic Article
|
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
|
|
Academic Article
|
Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial.
|
|
Academic Article
|
Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression.
|
|
Academic Article
|
Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series.
|